Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.

What Are the Latest Market Insights for the Personalized Genomics Industry?

The market size for personalized genomics has expanded swiftly over the past few years. The projected growth is from $8.15 billion in 2024 to a whopping $9.45 billion in 2025, experiencing a compound annual growth rate (CAGR) of 16.0%. This growth during the historical period can be credited to the heightened awareness of genetic risk elements in the general public, an increased incidence of chronic and hereditary illnesses, the progressive incorporation of AI and machine learning in genomic research, the rising interest in nutrigenomics and genomics based on lifestyle, and the escalating emphasis on companion diagnostics concerning oncology and rare diseases.

The market for personalized genomics is set to witness a massive upswing in the near future, with forecasts predicting a growth to $16.97 billion by 2029, growing at a CAGR of 15.8%. This anticipated growth during the forecast period can be traced back to the rising demand for personalized medicine, increasing consumer inclination towards DTC genetic testing, a surge in the adoption of preventive healthcare strategies, easier access to genomic data and bioinformatics tools, and a rise in partnerships between pharmaceutical and genomics firms. Key trends anticipated in the forecasted period include progress in NGS technologies, the utilization of AI in interpreting genomic data, the merging of genomics with electronic health records, advancements in the bioinformatics platform, and emergence of cloud-based genomic data storage and sharing systems.

Download The Free Sample Report Here:

https://www.thebusinessresearchcompany.com/sample.aspx?id=24654&type=smp

What Forces Are Driving The Growth Of The Personalized Genomics Industry?

The surge in chronic and rare diseases is anticipated to stimulate expansion in the personalized genomics market. Chronic diseases necessitate persistent management due to their enduring nature, whereas rare diseases, affecting only a minuscule segment of the population, often demand specific healthcare. A number of lifestyle elements like inadequate diet, sedentary behavior, and exposure to environmental risk factors are responsible for the increment in these diseases. Personalized genomics can enable precise disease diagnosis, formulate superior-targeted therapies, and enhance the management of conditions linked to specific genetic causes or risk factors by customizing treatments according to a person’s genetic profile. For example, the National Center for Biotechnology Information, a medical library based in the U.S, revealed that in January 2023, the count of individuals with at least one chronic disease is projected to surge by 99.5%, skyrocketing from 71.522 million in 2020 to 142.66 million by 2050. Therefore, this increase in chronic and rare diseases is a key driver in the growth of personalized genomics market.

What Is The Overview Of Market Segmentation In The Personalized Genomics Industry?

The personalized genomics market covered in this report is segmented –

1) By Test Type: Oncology Testing, Infectious Disease Testing, Neurological Testing, Cardiovascular Testing, Other Test Types

2) By Technology: Polymerase Chain Reaction-Based Tests, Microarray-Based Tests, Sequencing-Based Tests, Other Technologies

3) By Application: Diagnostics, Precision Medicine, Wellness, Reproductive Health, Sports Nutrition And Health, Lifestyle, Other Applications

4) By End User: Hospitals And Clinics, Research Centers, Pharmaceutical And Biotechnology Companies, Diagnostic Laboratories, Other End Users

Subsegments:

1) By Oncology Testing: Liquid Biopsy, Tumor Profiling, Genetic Testing For Cancer Risk, Companion Diagnostics

2) By Infectious Disease Testing: Hepatitis Testing, COVID-19 Testing, Respiratory Infections Testing, Sexually Transmitted Infections Testing

3) By Neurological Testing: Alzheimer’s Disease Testing, Huntington’s Disease Testing, Parkinson’s Disease Testing, Epilepsy Testing

4) By Cardiovascular Testing: Genetic Risk for Cardiovascular Diseases, Arrhythmia Testing, Lipid Panel Testing, Coronary Artery Disease Testing

5) By Other Test Types: Pharmacogenomics Testing, Genetic Screening For Inherited Disorders, Paternity Testing, Ancestry Testing

What Future Market Trends Are Projected For The Personalized Genomics Industry?

Leading businesses within the personalized genomics market are concentrating on the advancement of novel technologies, specifically personalized genomics systems, aiming to present bespoke insights into overall health, wellness, and the prevention of diseases. These platforms examine an individual’s genetic information to provide bespoke insights and advice regarding wellness, health, and disease susceptibility. A demonstration of this is the launch of Geniee Decode Your DNA, a bespoke genomics platform by Neuberg Diagnostics Private Limited, an India-based diagnostic service provider, in September 2024. This personalized genomics platform presents custom-made health, nutrition, and medication insights stemming from your genetic composition. Its function is to optimize wellness, aid in the prevention of diseases, and personalize medical treatments to enhance health results.

Who Are The Primary Players Operating Across The Global Personalized Genomics Market?

Major companies operating in the personalized genomics market are Thermo Fisher Scientific Inc., Illumina Inc., Myriad Genetics Inc., BGI Genomics Co. Ltd., Invitae Corporation, Guardant Health Inc., GeneDx LLC, Ancestry Inc., Oxford Nanopore Technologies plc, Genomic Health Inc., 23andMe Holding Co., Color Health Inc., Helix OpCo LLC, Personalis Inc., Dante Genomics, Gene By Gene Ltd., Veritas Genetics Inc., Futura Genetics, Nebula Genomics Inc., Pathway Genomics Corporation

Get The Full Report Here:

https://www.thebusinessresearchcompany.com/report/personalized-genomics-global-market-report

Which Region Offers The Most Growth Potential For The Personalized Genomics Market Through 2029?

North America was the largest region in the personalized genomics market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the personalized genomics market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request For A Customized Report:

https://www.thebusinessresearchcompany.com/customise?id=24654&type=smp

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model